Literature DB >> 24657439

PPNDS inhibits murine Norovirus RNA-dependent RNA-polymerase mimicking two RNA stacking bases.

Romina Croci1, Delia Tarantino1, Mario Milani2, Margherita Pezzullo2, Jacques Rohayem3, Martino Bolognesi1, Eloise Mastrangelo4.   

Abstract

Norovirus (NV) is a major cause of gastroenteritis worldwide. Antivirals against such important pathogens are on demand. Among the viral proteins that orchestrate viral replication, RNA-dependent-RNA-polymerase (RdRp) is a promising drug development target. From an in silico-docking search focused on the RdRp active site, we selected the compound PPNDS, which showed low micromolar IC50vs. murine NV-RdRp in vitro. We report the crystal structure of the murine NV-RdRp/PPNDS complex showing that two molecules of the inhibitor bind in antiparallel stacking interaction, properly oriented to block exit of the newly synthesized RNA. Such inhibitor-binding mode mimics two stacked nucleotide-bases of the RdRp/ssRNA complex.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antiviral discovery; In silico-docking; Norovirus; PPNDS; RNA-dependent-RNA-polymerase; X-ray crystallography

Mesh:

Substances:

Year:  2014        PMID: 24657439     DOI: 10.1016/j.febslet.2014.03.021

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

Review 1.  Current tools for norovirus drug discovery.

Authors:  Sahani Weerasekara; Allan M Prior; Duy H Hua
Journal:  Expert Opin Drug Discov       Date:  2016-05-02       Impact factor: 6.098

2.  P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.

Authors:  Talia H Swartz; Anthony M Esposito; Natasha D Durham; Boris M Hartmann; Benjamin K Chen
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

3.  Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives.

Authors:  Jacob Kocher; Lijuan Yuan
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

4.  In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase.

Authors:  Salvatore Ferla; Natalie E Netzler; Sebastiano Ferla; Sofia Veronese; Daniel Enosi Tuipulotu; Salvatore Guccione; Andrea Brancale; Peter A White; Marcella Bassetto
Journal:  Sci Rep       Date:  2018-03-07       Impact factor: 4.379

Review 5.  Structure(s), function(s), and inhibition of the RNA-dependent RNA polymerase of noroviruses.

Authors:  Jerome Deval; Zhinan Jin; Ying-Chih Chuang; C Cheng Kao
Journal:  Virus Res       Date:  2016-12-29       Impact factor: 3.303

6.  Potential Therapeutic Agents for Feline Calicivirus Infection.

Authors:  Tulio M Fumian; Daniel Enosi Tuipulotu; Natalie E Netzler; Jennifer H Lun; Alice G Russo; Grace J H Yan; Peter A White
Journal:  Viruses       Date:  2018-08-16       Impact factor: 5.048

Review 7.  Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy.

Authors:  Marcella Bassetto; Jana Van Dycke; Johan Neyts; Andrea Brancale; Joana Rocha-Pereira
Journal:  Viruses       Date:  2019-02-20       Impact factor: 5.048

8.  A new antiviral scaffold for human norovirus identified with computer-aided approaches on the viral polymerase.

Authors:  Gilda Giancotti; Ilaria Rigo; Gaia Pasqualetto; Mark T Young; Johan Neyts; Joana Rocha-Pereira; Andrea Brancale; Salvatore Ferla; Marcella Bassetto
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

9.  Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features.

Authors:  Valentina Speranzini; Dante Rotili; Giuseppe Ciossani; Simona Pilotto; Biagina Marrocco; Mariantonietta Forgione; Alessia Lucidi; Federico Forneris; Parinaz Mehdipour; Sameer Velankar; Antonello Mai; Andrea Mattevi
Journal:  Sci Adv       Date:  2016-09-09       Impact factor: 14.136

Review 10.  Structural biology in antiviral drug discovery.

Authors:  Marcella Bassetto; Alberto Massarotti; Antonio Coluccia; Andrea Brancale
Journal:  Curr Opin Pharmacol       Date:  2016-09-06       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.